Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?

被引:144
作者
Kuhn, L
Kasonde, P
Sinkala, M
Kankasa, C
Semrau, K
Scott, N
Tsai, WY
Vermund, SH
Aldrovandi, GM
Thea, DM
机构
[1] Columbia Univ, Sergievsky Ctr, New York, NY 10032 USA
[2] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA
[3] Columbia Univ, Dept Biostat, New York, NY 10032 USA
[4] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA
[5] Boston Univ, Sch Med, Ctr Int Hlth & Dev, Boston, MA 02215 USA
[6] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA
[7] Univ So Calif, Dept Pediat, Los Angeles, CA USA
[8] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia
[9] Lusaka Dist Hlth Management Team, Lusaka, Zambia
关键词
D O I
10.1086/498029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Rates of perinatal human immunodeficiency virus (HIV) transmission are higher among HIV-infected mothers with more advanced disease, but effects of maternal disease on HIV-uninfected offspring are unclear. We investigated the hypothesis that the severity of HIV disease and immune dysfunction among mothers is associated with increased morbidity and mortality among their uninfected infants. Methods. In a birth cohort of 620 HIV-uninfected infants born to HIV-infected mothers in Lusaka, Zambia, we investigated associations between markers of more advanced maternal HIV disease and child mortality, hospital admissions, and infant weight through 4 months of age. Results. Mortality in the cohort of uninfected infants was 4.6% (95% confidence interval [CI], 2.8-6.3) through 4 months of age. Infants of mothers with CD4(+) T cell counts of < 350 cells/mu L were more likely to die (hazard ratio [HR], 2.87; 95% CI, 1.03-8.03) and were more likely to be hospitalized (HR, 2.28; 95% CI, 1.17-4.45), after adjusting for other factors, including maternal death and low birth weight. The most common cause of infant death and hospitalization was pneumonia and/or sepsis. A maternal viral load of > 100,000 copies/mL was associated with significantly lower child weight through 4 months of age. Conclusion. Children born to HIV-infected mothers with advanced disease who escaped perinatal or early breastfeeding-related HIV infection are nonetheless at high risk of mortality and morbidity during the first few months of life. HIV-related immunosuppression appears to have adverse consequences for the health of infants, in addition to risks of vertical transmission.
引用
收藏
页码:1654 / 1661
页数:8
相关论文
共 38 条
  • [11] HIV-1 RNA detection in plasma for the diagnosis of infection in neonates
    Delamare, C
    Burgard, M
    Mayaux, MJ
    Blanche, S
    Doussin, A
    Ivanoff, S
    Chaix, ML
    Khan, C
    Rouzioux, C
    Akapko
    Allemon
    Allisy
    Armengaud
    Aufrant
    Babinet
    BaderMeunier
    Balde
    Baruchel
    Benichou
    Bensadoun
    Berterottiere
    Blanchard
    Boddaert
    Bompard
    Botto
    Boulley
    Braive
    Brault
    Broyart
    Brunner
    Cacault
    Carlus
    Chalvon
    Ciraru
    Clemencet
    Cohen
    ColinGorski
    Crumiere
    Dallot
    Dandine
    DeCrepy
    DeGennes
    Deberdt
    Debons
    Debre
    Denavit
    Devidas
    Donadieu
    Dubois
    Dumontel
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (02): : 121 - 125
  • [12] INCREASED RISK OF EARLY MEASLES IN INFANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SEROPOSITIVE MOTHERS
    EMBREE, JE
    DATTA, P
    STACKIW, W
    SEKLA, L
    BRADDICK, M
    KREISS, JK
    PAMBA, H
    WAMOLA, I
    NDINYAACHOLA, JO
    LAW, BJ
    PIOT, P
    HOLMES, KK
    PLUMMER, FA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (02) : 262 - 267
  • [13] Micronutrients and human immunodeficiency virus type 1 disease progression among adults and children
    Fawzi, W
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 : S112 - S116
  • [14] Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients
    Fidouh-Houhou, N
    Duval, X
    Bissuel, F
    Bourbonneux, V
    Flandre, P
    Ecobichon, JL
    Jordn, MC
    Vildé, JL
    Brun-Vézinet, F
    Leport, C
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1406 - 1411
  • [15] Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
    Garcia, PM
    Kalish, LA
    Pitt, J
    Minkoff, H
    Quinn, TC
    Burchett, SK
    Kornegay, J
    Jackson, B
    Moye, J
    Hanson, C
    Zorrilla, C
    Lew, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) : 394 - 402
  • [16] Cytomegalovirus (CMV) viremia and the CD4(+) lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus
    Gerard, L
    Leport, C
    Flandre, P
    Houhou, B
    SalmonCeron, D
    Pepin, JM
    Mandet, C
    BrunVezinet, F
    Vilde, JL
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 836 - 840
  • [17] Quantitation of human immunodeficiency virus type 1 in breast milk
    Ghosh, MK
    Kuhn, L
    West, J
    Semrau, K
    Decker, D
    Thea, DM
    Aldrovandi, GM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) : 2465 - 2470
  • [18] Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial
    Guay, LA
    Musoke, P
    Fleming, T
    Bagenda, D
    Allen, M
    Nakabiito, C
    Sherman, J
    Bakaki, P
    Ducar, C
    Deseyve, M
    Emel, L
    Mirochnick, M
    Fowler, MG
    Mofenson, L
    Miotti, P
    Dransfield, K
    Bray, D
    Mmiro, F
    Jackson, JB
    [J]. LANCET, 1999, 354 (9181) : 795 - 802
  • [19] Performance Characteristics of HIV-1 Culture and HIV-1 DNA and RNA Amplification Assays for Early Diagnosis of Perinatal HIV-1 Infection
    Lambert, John S.
    Harris, D. Robert
    Stiehm, E. Richard
    Moye, John, Jr.
    Fowler, Mary Glenn
    Meyer, William A., III
    Bethel, James
    Mofenson, Lynne M.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (05) : 512 - 519
  • [20] Immune restoration with antiretroviral therapies - Implications for clinical management
    Lederman, MM
    Valdez, H
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02): : 223 - 228